| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| David Hinkle | SVP, Finance and Controller Principal Accounting Officer | Jan 22, 2025 | |||
| Nancy Whiting | Director | Mar 27, 2024 | |||
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10%+ Owner | Apr 2, 2024 | |||
| Jennifer Lew | Director | Mar 27, 2024 | |||
| ARCH Venture Fund IX, L.P. | 10%+ Owner | Apr 2, 2024 | |||
| Christian Hassig | Chief Scientific Officer | Jan 22, 2025 | |||
| James Christensen | Director | Mar 27, 2024 | |||
| Klaus Wagner | Chief Medical Officer | Aug 19, 2024 | |||
| Keith Crandell | 10%+ Owner | Apr 2, 2024 | |||
| Kristina Burow | Director, 10%+ Owner | Apr 2, 2024 | |||
| Christine Brennan | Director | Mar 27, 2024 | |||
| Neil Abdollahian | Chief Business Officer | Aug 19, 2024 | |||
| Jami Rubin | Chief Financial Officer | Aug 19, 2024 | |||
| Jonathan E. Lim | Director | Jun 20, 2024 | |||
| Zachary Hornby | President & CEO, Director | Jan 22, 2025 | |||
| Ra Capital Management, L.P. | 10%+ Owner | Apr 2, 2024 | |||
| Jessica Oien | Chief Legal Officer and Corporate Secretary | Jan 22, 2025 | |||
| Robert Doebele | Chief Medical Officer | Feb 3, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|